News & Updates
Showing Multidisciplinary articles
Showing

Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA
Male sex, elevated C-reactive protein (CRP), lower number of previous biologic/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) used, and lower Health Assessment Questionnaire (HAQ) score are all predictive of treatment response in European patients with psoriatic arthritis (PsA) treated with secukinumab, a study has shown.
Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA
15 Sep 2026
AI + mammography: A new gateway for CVD detection?
A retrospective analysis presented at ESC 2026 demonstrates the ability of artificial intelligence (AI) to detect cardiovascular diseases (CVDs) from routine mammograms.
AI + mammography: A new gateway for CVD detection?
15 Sep 2026
Aficamten retains upper hand over metoprolol for oHCM in subanalysis
Results from a subanalysis of the MAPLE-HCM* trial presented at ESC 2026 continue to support the superiority of aficamten over metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) irrespective of beta-blocker (BB) use at screening and prior standard-of-care (SoC) status.






